Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 170 KB, PDF-dokument

A 61-year-old male on everolimus had chronic SARS-CoV-2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID-19.

OriginalsprogEngelsk
Artikelnummere04218
TidsskriftClinical Case Reports
Vol/bind9
Udgave nummer6
ISSN2050-0904
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
Published with written consent of the patient.

Publisher Copyright:
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

ID: 305536585